Company Information

WELCURE DRUGS & PHARMACEUTICALS LTD.

NSE : NABSE : 524661ISIN CODE : INE331C01017Industry : TradingHouse : Private
BSE4.870.07 (+1.46 %)
PREV CLOSE ( ) 4.80
OPEN PRICE ( ) 4.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 45156
TODAY'S LOW / HIGH ( )4.85 4.87
52 WK LOW / HIGH ( ) 3.25.48
NSE
This Company is not listed in NSE
Managing DirectorAltaf Hussain Shah
Company SecretaryManowar Ali
Independent DirectorAshish Abbi
Non Executive Independent DirectorSuraj Chagan Solanki
Deepika Krishnan Iyer
Incorporation Year : 06-08 1996

Registered Office :

Address : Plot No. 55, Office No. 104,First Floor, Vijay Black,Laxmi Nagar Delhi,
Delhi-110092 .

Phone :

Industry : Trading

Listing : BSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.